Search research articles
Contact Us
Filters
Showing results (201-210 of 286) with videos related to
Page
of 29
Sort By:
Cell Cycle (Georgetown, Tex.)
|
April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Frontiers in Oncology
|
December 24, 2025
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
December 31, 2024
Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
February 26, 2025
Dynamic Fluorescence Imaging of Orally-administered Tumor-targeting <i>Salmonella typhimurium</i> A1-R Expressing Green Fluorescent Protein Trafficking Through the Gastrointestinal System to Target Fibrosarcomas in Nude Mice
Sei Morinaga, Ming Zhao, Kohei Mizuta, et al.
Cancer Diagnosis & Prognosis
|
January 6, 2025
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
December 3, 2024
Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
October 30, 2024
Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Journal of Clinical Medicine
|
November 27, 2024
Serum Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibody Levels Are Involved in Rheumatoid Arthritis Complicated with Interstitial Lung Disease
Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, et al.
Biochemical and Biophysical Research Communications
|
April 9, 2019
Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model
Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, et al.
Biochemical and Biophysical Research Communications
|
December 31, 2022
Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer
Masuyo Miyake, Kentaro Miyake, Qinghong Han, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 286) with videos related to
Sort By:
Page
of 29
Cell Cycle (Georgetown, Tex.)
|
April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Frontiers in Oncology
|
December 24, 2025
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
December 31, 2024
Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
February 26, 2025
Dynamic Fluorescence Imaging of Orally-administered Tumor-targeting <i>Salmonella typhimurium</i> A1-R Expressing Green Fluorescent Protein Trafficking Through the Gastrointestinal System to Target Fibrosarcomas in Nude Mice
Sei Morinaga, Ming Zhao, Kohei Mizuta, et al.
Cancer Diagnosis & Prognosis
|
January 6, 2025
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
December 3, 2024
Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
October 30, 2024
Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Journal of Clinical Medicine
|
November 27, 2024
Serum Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibody Levels Are Involved in Rheumatoid Arthritis Complicated with Interstitial Lung Disease
Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, et al.
Biochemical and Biophysical Research Communications
|
April 9, 2019
Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model
Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, et al.
Biochemical and Biophysical Research Communications
|
December 31, 2022
Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer
Masuyo Miyake, Kentaro Miyake, Qinghong Han, et al.
Page
of 29